NewsEvents

Your Yourlocation: Home > Efficacy and safety of tiotropium bromide(136310-93-5) and budesonide /formoterol in the treatment of chronic obstructive pulmonary disease

To observe the therapeutic effect of salmeterol in combination with tiotropium bromide(136310-93-5) inhalation on chronic obstructive pulmonary disease (COPD). METHODS: Forty-eight patients with COPD were divided into observation group and control group by randomized, double-blind method. Group A was treated with tiotropium bromide(136310-93-5) and salmeterol /propafenone propionate. Group B was given salmeterol / Treatment with fluticasone propionate. The scores of dyspnea before and after treatment were compared with those of 6 min walking distance (6MWT). Results: Compared with the control group, the pulmonary function indexes FEV1, FEV1 / FVC%, quality of life score and 6MWT were observed after 3 months of treatment (P <0.05). Conclusion: Tiotropium bromide(136310-93-5) combined with salmeterol in combination with inhalation treatment of COPD, the effect is better than salmeterol tacicon monotherapy.

Inhalation of tiotropium in the treatment of moderate to severe COPD is simple, safe and reliable, the results are satisfactory. Are reported as follows. All cases within 1 year have acute exacerbation of treatment, nearly a month in the stable use of hormones, bronchodilators and other drugs, and exclude acute respiratory failure, chronic heart failure, cancer and other life-threatening diseases, excluding the history of bronchial asthma.

Address: TEL:0531-82375879 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved